PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of cviPermissionsJournals.ASM.orgJournalAEM ArticleJournal InfoAuthorsReviewers
 
Clin Vaccine Immunol. 2010 April; 17(4): 651–659.
Published online 2010 February 17. doi:  10.1128/CVI.00494-09
PMCID: PMC2849320

Interactive Changes between Macrophages and Adipocytes[down-pointing small open triangle]

Abstract

Obesity is associated with a proinflammatory state, with macrophage infiltration into adipose tissue. We tested the hypothesis that communication between macrophages and adipocytes affects insulin resistance by disrupting insulin-stimulated glucose transport, adipocyte differentiation, and macrophage function. To test this hypothesis, we cocultured 3T3-L1 adipocytes with C2D macrophages or primary peritoneal mouse macrophages and examined the impacts of macrophages and adipocytes on each other. Adipocytes and preadipocytes did not affect C2D macrophage TNF-α, IL-6, or IL-1β transcript concentrations relative to those obtained when C2D macrophages were incubated alone. However, preadipocytes and adipocytes increased PEC-C2D macrophage IL-6 transcript levels, while preadipocytes inhibited IL-1β transcript levels compared to those obtained when PEC-C2D macrophages were incubated in medium alone. We found that adipocyte coculture increased macrophage consumption of tumor necrosis factor alpha (TNF-α), interleukin 1β (IL-1β), and, in some cases, IL-6. C2D macrophages increasingly downregulated GLUT4 transcript levels in differentiated adipocytes. Recombinant TNF-α, IL-1β, and IL-6 also downregulated GLUT4 transcript levels relative to those for the control. However, only IL-6 was inhibitory at concentrations detected in macrophage-adipocyte cocultures. IL-6 and TNF-α, but not IL-1β, inhibited Akt phosphorylation within 15 min of insulin stimulation, but only IL-6 was inhibitory 30 min after stimulation. Lastly, we found that adipocyte differentiation was inhibited by macrophages or by recombinant TNF-α, IL-6, and IL-1β, with IL-6 having the most impact. These data suggest that the interaction between macrophages and adipocytes is a complex process, and they support the hypothesis that the macrophage-adipocyte interaction affects insulin resistance by disrupting insulin-stimulated glucose transport, adipocyte differentiation, and macrophage function.

Insulin resistance is characterized as an impairment of glucose utilization and reduced insulin signaling in peripheral tissues. There appears to be a relationship between inflammation and the development of insulin resistance (26). One hypothesis is that inflammation causes “metabolic syndrome,” which is defined as a combination of symptoms associated with insulin resistance and known to precede the onset of type 2 diabetes (18, 24).

Insulin resistance accompanies not only chronic inflammation but also abnormal mediator secretion (42). Adipose tissue is now appreciated as an endocrine organ that secretes hormones and cytokines, including inflammatory cytokines, such as tumor necrosis factor alpha (TNF-α), interleukin-1β (IL-1β), and IL-6 (17). The cytokines are associated with increased numbers of adipose tissue macrophages in obese and diabetic patients (41, 46). In fact, macrophage recruitment increases with fat mass (32). Direct or indirect interactions between adipose tissue macrophages and adipocytes may impair insulin action, affect key protein expression, or activate inflammatory pathways. For example, levels of TNF-α, IL-6, C-reactive protein (CRP), and monocyte chemoattractant protein-1 (MCP-1; also referred to as CCL-2) are elevated in obese and diabetic people (4, 6, 47). In the obese mouse (ob/ob), the absence of TNF-α improved insulin sensitivity and glucose homeostasis (39). The adoptive transfer of bone marrow cells from normal mice into TNF-α knockout mice reduced the insulin sensitivity of the recipients (9). Therefore, it is clear that TNF-α has an impact on insulin sensitivity. However, it is not clear if TNF-α is the only cytokine that is required for the induction of insulin resistance. IL-6 is overexpressed in adipose tissue of obese and diabetes patients (40). Elevated IL-6 levels correlated with reduced adiponectin concentrations in human adipose tissue and reduced transcription of insulin receptor substrate-1 (IRS-1) and glucose transporter 4 (GLUT4) in 3T3-L1 cells (4, 21, 35). IL-1β levels have also been reported to be higher in overweight and obese individuals than in lean individuals (38) and have been shown to cause reduced IRS downregulation in differentiated 3T3-L1 adipocytes (22). Moreover, individuals with a combined increase in IL-1β and IL-6 levels were at greater risk of developing type-2 diabetes than individuals with increased IL-6 levels alone (33).

Collectively, these data suggest that TNF-α, IL-1β, and IL-6 play critical roles in the onset of obesity-related insulin resistance. However, both macrophages and adipocytes produce proinflammatory cytokines. Given that these cytokines synergize and regulate each other (10), there are many unanswered questions about what happens during the adipocyte-macrophage interaction and how insulin resistance is induced.

We hypothesized that macrophage-adipocyte communication would affect glucose uptake and the signaling that occurs in response to insulin. To test this hypothesis, we cocultured macrophages and adipocytes, and we examined the impact of the interaction on both cell types.

MATERIALS AND METHODS

Antibodies and recombinant cytokines.

Mouse recombinant TNF-α, IL-1β, and IL-6 were purchased from R&D Systems (Minneapolis, MN). A rabbit polyclonal antibody against mouse GLUT4 (catalog no. ab654-250) was obtained from Abcam (Cambridge, MA). A rabbit polyclonal antibody against mouse GLUT1 (catalog no. CBL242) was obtained from BD Biosciences (San Jose, CA). A rabbit polyclonal antibody against Akt (catalog no. 9272) and rabbit anti-phospho-Akt (serine 473; catalog no. 9271S) were obtained from Cell Signaling (Beverly, MA). Allophycocyanin (APC)-conjugated goat anti-rabbit IgG (catalog no. sc-3846) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Alexa Fluor 647-conjugated Mac-2 (catalog no. 51-5301-82) and its isotype Alexa Fluor 647-conjugated IgG2a (catalog no. 51-4321-80), APC-conjugated CD11b (catalog no. 17-0112-82) and its isotype APC-conjugated IgG2b (catalog no. 17-4031-82), and APC-conjugated streptavidin (catalog no. 17-4317-82) were purchased from eBioscience (San Diego, CA). Biotin-conjugated Ly-6C (catalog no. 557359) and biotin-conjugated IgM (catalog no. 559941) were purchased from BD Biosciences. For enzyme-linked immunosorbent assays (ELISA), an anti-TNF-α antibody (for capture; catalog no. 551225), a biotinylated anti-TNF-α antibody (for detection; catalog no. 554415), an anti-IL-6 antibody (for capture; catalog no. 554400), and a biotinylated anti-IL-6 antibody (for detection; catalog no. 554402) were obtained from BD Biosciences (San Jose, CA); an anti-IL-1β antibody (for capture; catalog no. MAB401) and a biotinylated anti-IL-1β antibody (for detection; catalog no. BAF401) were obtained from R&D Systems (Minneapolis, MN).

Cell culture.

3T3-L1 adipocytes were obtained from the American Type Culture Collection (Manassas, VA). Adipocytes were cultured and differentiated as described previously (43, 44). The C2D macrophage cell line was created by our group and was cultured in DMEM2 as described previously (3).

Peritoneal macrophages were obtained from C57BL/6J (B6) mice by peritoneal lavage 4 days after intraperitoneal injection of 1.5 ml of 4% thioglycolate. Macrophages were incubated in ammonium chloride lysis buffer (0.15 M NH4Cl, 10 mM KHCO3, 0.1 mM disodium EDTA [pH 7.3]) for 5 min on ice to lyse contaminating red blood cells. Cells were washed three times with phosphate-buffered saline (PBS) (137 mM NaCl, 10 mM phosphate, 2.7 mM KCl [pH 7.4]). Indirect (transwell) coculture was performed by incubating peritoneal macrophages (1 × 106 cells) or C2D macrophages (1 × 105 cells) in 0.4-μm-pore-size cell culture inserts (BD Bioscience) and placing them in 6-well plates containing 3T3-L1 adipocytes differentiated for 8 days (1 × 106 cells). Cocultures were incubated for 4 days. Direct coculture was performed by directly adding peritoneal macrophages (1 × 106 viable cells; trypan blue exclusion) or C2D macrophages (1 × 105 viable cells; trypan blue exclusion) to the 6-well plates containing undifferentiated 3T3-L1 adipocytes (1 × 106 cells). Fewer C2D macrophages were added, because they continue to proliferate (cell cycle time [T1/2], ≈24 h) (3), while peritoneal macrophages do not. Macrophages did not appear apoptotic or necrotic after the 4-day incubation period, as assessed by light microscopic examination.

Adoptive transfer of labeled cells.

C2D cells were suspended in sterile, prewarmed (37°C) PBS at a concentration of 1.5 × 106 per ml. Cells were stained with carboxyfluorescein diacetate succinimidyl ester (CFDA-SE) according to the manufacturer's protocol (28, 29). Briefly, C2D cells were incubated with 22 μM CFDA-SE solution at 37°C for 15 min. After centrifugation at 370 × g for 10 min, cell pellets were suspended in prewarmed PBS and incubated at 37°C for an additional 20 min. Cells were then washed twice in PBS and were suspended at a concentration of 3 × 107/ml in PBS. One and one-half milliliters of the suspension of CFDA-SE-labeled C2D cells or normal C2D cells was injected intraperitoneally (i.p.) per mouse.

Quantitative RT-PCR analysis.

One-step quantitative reverse transcription-PCR (qRT-PCR) was performed using the SuperScript III Platinum SYBR green kit (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. Primers were designed with PrimerQuest software (Integrated DNA Technologies) using sequence data from the NCBI sequence database, as follows: for ACDC (NM_AB008453), primers 5′-AGACCTGGCCACTTTCTCCTCATT (forward) and 5′-AGAGGAACAGGAGAGCTTGCAACA (reverse); for GLUT1, 5′-TCAACGAGCATCTTCGAGAAGGCA (forward) and 5′-TCGTCCAGCTCGCTCTACAACAAA (reverse); for GLUT4, 5′-TTCACGTTGGTCTCGGTGCTCTTA (forward) and 5′-CCACAAAGCCAAATATGGCCACGA (reverse); for TNF-α (NM_013693), 5′-TCTCATGCACCACCATCAAGGACT (forward) and 5′-TGACCACTCTCCCTTTGCAGAACT (reverse); for IL-6 (NM_031168.1), 5′-TCTCATGCACCACCATCAAGGACT (forward) and 5′-TGACCACTCTCCCTTTGCAGAACT (reverse); for IL-1β (NM_008361), 5′-AAGGGCTGCTTCCAAACCTTTGAC (forward) and 5′-ATACTGCCTGCCTGAAGCTCTTGT (reverse); for Arg-1 (NM_007482), 5′-TGGCTTTAACCTTGGCTTGCTTCG (forward) and 5′-CATGTGGCGCATTCACAGTCACTT (reverse); for Ym-1 (M94584), 5′-CACCATGGCCAAGCTCATTCTTGT (forward) and 5′-TATTGGCCTGTCCTTAGCCCAACT (reverse); for Fizz-1 (NM_020509.3), 5′-ACTGCCTGTGCTTACTCGTTGACT (forward) and 5′-AAAGCTGGGTTCTCCACCTCTTCA (reverse); and for β-actin (NM_007393), 5′-TGTGATGGTGGGAATGGGTCAGAA (forward) and 5′-TGTGGTGCCAGATCTTCTCCATGT (reverse). The qRT-PCRs were performed in a SmartCycler system (Cepheid, Sunnyvale, CA). The fold increase in transcript expression was calculated as [E(gene of interest)ΔCT target]/ [E(housekeeping)ΔCT housekeeping], where E (efficiency) is equal to 10(−1/slope), as described previously by Pfaffl (27).

Flow cytometry analysis.

Cells were detached with a 0.02% EDTA-PBS solution, transferred to the wells of 96-well round-bottom plates, and blocked with PBS-goat serum (at 50% each; 50 μl) at 4°C for 0.5 h. Blocked cells were incubated with the specific antibody or isotype control diluted in Hanks buffered salt solution (HBSS) (0.137 M NaCl, 5.4 mM KCl, 0.25 mM Na2HPO4,0.44 mM KH2PO4, 1.3 mM CaCl2, 1.0 mM MgSO4, 4.2 mM NaHCO3) for 1 h in the dark at 4°C. After two washes with HBSS, cells were fixed in 1% formalin. For indirect labeling, blocked cells were incubated for 1 h with a primary antibody or isotype control antibody diluted in HBSS at a total volume of 50 μl. Incubation continued in the dark for 1 h at 4°C. Thereafter, cells were washed twice with HBSS. Secondary antibodies diluted in HBSS for a 50-μl final volume were added to the cells and incubated for 40 min in the dark at 4°C. Cells were washed twice with HBSS and then fixed in 1% formalin. Labeled cell surface proteins were assessed by flow cytometry.

For the analysis of the intracellular molecules, cells were first fixed in 2% paraformaldehyde for 20 min at 37°C. Cells were then permeabilized by incubation in 90% ice-cold methanol for 30 min. The cells were washed twice in PBS and were then blocked and probed with antibody as described above. Samples were analyzed using a FACSCalibur analytical flow cytometer (Becton Dickinson, San Jose, CA); 5,000 to 10,000 events were measured for each sample. Data analysis was performed with Winlist software (Verity Software House, Topsham, ME).

Cytokine detection.

Granulocyte-macrophage colony-stimulating factor (GM-CSF), gamma interferon (IFN-γ), IL-1α, IL-2, IL-4, IL-5, IL-6, IL-10, IL-17, and TNF-α were detected in cell culture supernatants using a mouse Th1/Th2 10-plex FlowCytomix multiplex kit, purchased from Bender Medsystems (Burlingame, CA), according to the manufacturer's instructions.

TNF-α, IL-1β, and IL-6 in cell culture supernatants were also measured by ELISA (7). Briefly, the ELISA plates were coated with capture antibodies overnight at room temperature. After 1 h of blocking, samples were added to each well and were incubated at room temperature for 2 h. Wells were washed three times with PBS supplemented with 0.5% Tween 20 (PBST). Biotin-conjugated detection antibodies were added and incubated at room temperature for 2 h. Horseradish peroxidase (HRP)-conjugated streptavidin was then added and incubated at room temperature for 30 min. After three washes, the substrate was added to the wells. Within 30 min, the reaction was stopped by the addition of 50 μl of 1 N H2SO4, and absorbance was assessed using a Bio-Rad microplate reader, model 680 (Bio-Rad Laboratories, Inc., Hercules, CA) at 450 nm.

Assessment of 3T3-L1 adipocyte differentiation.

3T3-L1 fibroblasts were induced to differentiate for 4 days as described previously (43). On day 4, peritoneal macrophages were either plated onto the insert of the transwell or added directly to the 3T3-L1 cells for 4 days. In the cytokine impact studies, TNF-α, IL-6, or IL-1β was added to the 3T3-L1 cells for 4 days. On day 8, adipocytes were fixed on the plate with 2% paraformaldehyde at 4°C for 15 min. The cells were washed twice with PBS and were stained with Sudan IV-saturated 70% isopropanol for 15 min. Cells were then washed twice with 50% isopropanol. Cells were mounted directly onto the plate using several drops of glycerol, viewed under a light microscope, and photographed. To measure the differentiation based on the amount of lipid present in the cells, absorbance was read at 550 nm using a Packard SpectraCount spectrophotometer (Packard Instrument Company, Meriden, CT).

Statistical analysis.

Differences in means were determined using Student's t test (paired, two-tailed). All tests were calculated using the StatMost statistical package (Dat@xiom Software, Los Angeles, CA). Differences were considered significantly different when P was <0.05.

RESULTS

Reduced levels of GLUT4 transcripts in 3T3-L1 adipocytes cocultured with macrophages.

We observed higher levels of GLUT1 transcripts in 3T3-L1 adipocytes cocultured with peritoneal macrophages than in adipocytes cultured alone, regardless of the differentiation stage examined (Table (Table1).1). However, the most pronounced increase occurred in the early differentiated cells (days 0 to 4). Adiponectin transcript levels were unchanged from those in adipocytes incubated alone at days 0 to 4 of coculture with macrophages, but transcript levels decreased significantly at days 4 to 8 and 8 to 12 of coculture with macrophages. GLUT4 gene transcript levels were reduced at days 4 to 8 and 8 to 12 of culture with peritoneal macrophages. Therefore, macrophages had a differential impact on GLUT1, GLUT4, and ACDC transcript levels as 3T3-L1 cells underwent differentiation.

TABLE 1.
Influence of peritoneal macrophages on the levels of adiponectin (ACDC), GLUT1, and GLUT4 transcripts in 3T3-L1 adipocytesa

Cytokine secretion in 3T3-L1 adipocyte-macrophage cocultures was altered.

The differential impact of peritoneal macrophages on 3T3-L1 adipocytes cocultured separately in transwell cultures is consistent with previous observations that cytokines played a role in the adipocyte-macrophage interaction (18, 33). Therefore, we assessed an array of cytokines, including IFN-γ, IL-1α, IL-2, IL-4, IL-5, IL-10, IL-17, and GM-CSF (data not shown), along with IL-1β, TNF-α, and IL-6, for changes during macrophage-adipocyte coculture. Only IL-1β, TNF-α, and IL-6 secretion was altered in the adipocyte-macrophage cocultures when we assessed these cytokines in the supernatants either by array or by ELISA. Both B6 peritoneal macrophages and 3T3-L1 adipocytes secreted TNF-α, IL-1β, and IL-6 (Fig. (Fig.1).1). For this reason, we compared the secretion of the cytokines in supernatants from cocultures to the sum of the secretions by 3T3-L1 cells and macrophages when they were cultured alone (bars stacked together in Fig. Fig.1).1). We found that the concentrations of TNF-α (Fig. (Fig.1A)1A) and IL-1β (Fig. (Fig.1C)1C) in both direct (cells incubated together [mix]) and indirect (transwell) cocultures were significantly lower than the sum of the levels secreted by adipocytes and macrophages cultured alone. The levels of TNF-α and IL-1β in direct versus indirect cocultures did not differ. However, the amounts of IL-6 detected in direct coculture were different from those in transwell culture. The level of IL-6 detected in direct coculture was higher than the sum of the levels of IL-6 detected in adipocytes and macrophages cultured alone, whereas the IL-6 level in transwell culture was significantly lower than that sum (Fig. (Fig.1B1B).

FIG. 1.
Secretion of TNF-α, IL-6, and IL-1β in macrophage and 3T3-L1 adipocyte cocultures. 3T3-L1 adipocytes and peritoneal (PC) macrophages were either incubated alone, coincubated directly (mix), or coincubated but separated in transwell plates ...

Effects of 3T3-L1 adipocyte differentiation and macrophage maturity on cytokine expression.

TNF-α has been reported to be the major mediator in the induction of the “inflammatory fire” of the adipose tissue environment (16, 26). However, our data (Fig. (Fig.1)1) suggested that IL-6 production may be regulated differently from TNF-α production. Since the adipose tissue environment is a mixture of both mature and immature adipocytes as well as both mature and immature macrophages, we tested the hypothesis that preadipocytes and adipocytes will differentially regulate immature and mature macrophages and the cytokines produced. To test this hypothesis, we performed the experiment with the C2D macrophage line (3, 28, 29). C2D macrophages have an early macrophage lineage phenotype when grown in vitro. They do not secrete TNF-α or IL-1β in vitro, and they express a phenotype characteristic of more-differentiated macrophages only after they are adoptively transferred to the peritoneal cavity (PEC-C2D) (28, 29). This phenotype is accompanied by increased cytokine transcription/secretion. Therefore, this model system allowed us to compare the impact of preadipocytes or adipocytes on cytokine transcript levels in both early differentiated and late differentiated macrophages. C2D macrophages were labeled with CFDA-SE so that they could be purified by fluorescence-activated cell sorting after being injected in vivo and after they were cultured with adipocytes or preadipocytes for 2 days.

Cytokine gene transcripts were detected by qRT-PCR (Table (Table2).2). We observed low levels of TNF-α, IL-1β, and IL-6 transcripts in C2D cells incubated with adipocytes or preadipocytes. These data suggest that adipocytes or preadipocytes have no physiological impact on C2D macrophages, since C2D macrophage controls incubated in medium alone normally have low transcription of these cytokines. However, we found higher IL-6 transcript levels in PEC-C2D macrophages incubated with either adipocytes or preadipocytes than in PEC-C2D macrophages incubated alone. IL-1β transcript levels were significantly lower in PEC-C2D macrophages incubated with preadipocytes. Therefore, macrophage cytokine transcript regulation was dependent on macrophage differentiation, and adipocyte differentiation had some impact.

TABLE 2.
Influence of adipocytes or preadipocytes on cytokine transcript levels in macrophagesa

Effects of 3T3-L1 adipocyte differentiation on macrophage phenotype.

C2D macrophages cultured in vitro express low levels of Mac-2 and Ly-6C, and almost no CD11b, indicative of an immature macrophage phenotype (28, 29). We observed no changes in any of the three cell surface markers on C2D macrophages cocultured with preadipocytes (Fig. (Fig.2A)2A) from those on C2D macrophages cultured alone. However, we observed a small but significant (P, <0.05) increase in CD11b expression and a significant decrease in Ly-6C expression on C2D macrophages cocultured with adipocytes (Fig. (Fig.2A2A).

FIG. 2.
Percentage of CFDA-SE-positive C2D cells testing positive for a given marker. (A) CFDA-SE-labeled C2D macrophages grown in vitro were either cultured alone or cocultured with adipocytes or with preadipocytes. (B) CFDA-SE-labeled C2D macrophages were adoptively ...

When we cocultured PEC-C2D macrophages with adipocytes or preadipocytes and measured the expression of macrophage markers, we found that adipocytes induced significantly more Mac-2 expression on PEC-C2D macrophages than that found on PEC-C2D macrophages incubated alone or with preadipocytes in vitro (Fig. (Fig.2B).2B). We observed small but significant decreases in CD11b and Mac-2 levels in macrophages cocultured with preadipocytes from the levels in PEC-C2D macrophages incubated in medium alone (Fig. (Fig.2B).2B). These data suggest that adipocytes alter the C2D macrophage phenotype differently from preadipocytes and that the differentiation state of the macrophage was important.

TNF-α, IL-1β, and IL-6 decrease GLUT4 transcript and protein levels in adipocytes.

Coculture of adipocytes and macrophages increased IL-6 and IL-1β transcript levels in PEC-C2D macrophages (Table (Table2).2). To assess the relative importance of these cytokines in glucose resistance, we examined the effects of recombinant TNF-α, IL-1β, and IL-6 on GLUT4 gene transcription in adipocytes. We treated fully differentiated adipocytes with TNF-α (2 ng/ml), IL-1β (20 ng/ml), or IL-6 (10 ng/ml) for 48 h and subsequently measured the ACDC, GLUT1, and GLUT4 mRNA levels by qRT-PCR. We found that TNF-α did not significantly affect ACDC or GLUT1 transcript levels (Table (Table3).3). IL-6 also did not significantly influence GLUT1 mRNA levels. However, GLUT4 transcript levels were significantly reduced by TNF-α, IL-6, and IL-1β from levels in untreated 3T3-L1 controls (Table (Table3).3). When we assessed the action of TNF-α, IL-1β, and IL-6 on 3T3-L1 GLUT4 and GLUT1 protein expression using flow cytometry in permeabilized adipocytes, we found that each of the three cytokines (TNF-α, IL-1β, or IL-6) significantly decreased total GLUT4 protein levels (Fig. (Fig.3A)3A) but not GLUT1 protein levels (Fig. (Fig.3B3B).

FIG. 3.
Effects of recombinant TNF-α, IL-6, and IL-1β on GLUT4 protein expression. Fully differentiated adipocytes were incubated in medium containing recombinant mouse TNF-α (2 ng/ml), IL-6 (10 ng/ml), or IL-1β (20 ng/ml) for ...
TABLE 3.
Influence of cytokines on the regulation of the ACDC, GLUT1, and GLUT4 genes in 3T3-L1 adipocytesa

TNF-α, IL-6, and IL-1β affect Akt phosphorylation differently.

GLUT4 translocation is triggered by insulin through phosphoinositide 3-kinase (PI3K) activation, leading to phosphorylation of the Akt protein within 15 min after insulin treatment (11). Therefore, we evaluated the relative importance of TNF-α, IL-1β, and IL-6 for Akt phosphorylation in adipocytes by using flow cytometry. None of the cytokine treatments altered total cellular Akt protein levels (Fig. (Fig.4A).4A). However, when we measured the level of phosphorylation of Akt at Ser473 at 0, 5, 10, 15, and 30 min following insulin stimulation, we observed that phosphorylation peaked at 15 min after the insulin treatment and that by 30 min, Ser473-Akt phosphorylation was diminished (Fig. (Fig.4B).4B). Adipocytes treated with IL-1β showed a time-dependent phosphorylation pattern similar to that seen for control adipocytes (Fig. (Fig.4B).4B). In contrast, Ser473-Akt phosphorylation remained at baseline levels in adipocytes treated with IL-6 (Fig. (Fig.4B),4B), with almost 100% inhibition. Unlike IL-6, TNF-α did not completely block insulin signaling. It delayed the phosphorylation of Akt for approximately 10 min.

FIG. 4.
TNF-α, IL-6, and IL-1β affect Akt phosphorylation differently. Fully differentiated adipocytes were incubated with or without (control) recombinant mouse TNF-α, IL-6, or IL-1β for 2 days. (A) Total Akt protein levels were ...

Τo confirm that TNF-α inhibited the phosphorylation of Akt for 15 min after insulin stimulation; we treated cells with different concentrations of IL-6 or TNF-α for 48 h. Then we stimulated the cells with insulin for 15 min and determined the level of phosphorylation of Akt at Ser473. There was a dose-dependent inhibition of Akt phosphorylation by IL-6 or TNF-α (Fig. (Fig.4C4C).

TNF-α, IL-6, and IL-1β inhibit 3T3-L1 differentiation.

Preadipocytes accumulate less fat and have reduced gene expression of adipogenic and lipogenic markers when the cells are induced to differentiate in the presence of a macrophage-conditioned medium (20). Therefore, we hypothesized that the direct inhibitory impact of macrophages on GLUT4 transcription and Akt phosphorylation would be exacerbated if macrophages also inhibited adipocyte differentiation. To test this possibility, we used Sudan IV staining to assess intracellular lipid content. 3T3-L1 cells synthesize increased amounts of lipids as they differentiate, resulting in an increase in the size of the intracellular lipid pool (13). We observed less Sudan IV staining of 3T3-L1 cells cocultured with thioglycolate-elicited peritoneal macrophages than of controls, regardless of whether the macrophages and adipocytes were separated in transwells or were mixed together (Fig. 5A and B). We found a macrophage number-dependent inhibition of 3T3-L1 adipocyte differentiation (Fig. (Fig.5B).5B). It is possible that the impact of the macrophages was not only direct (i.e., due to contact with cytokines) but was also due to the low availability of nutrients to the adipocytes because of increased numbers of macrophages in the culture. Therefore, we also assessed the effects of TNF-α, IL-6, and IL-1β on 3T3-L1 differentiation. Adipocytes were incubated with varying concentrations of cytokines, ranging from 0.5 to 2 ng/ml of TNF-α, 1 to 20 ng/ml of IL-1-β, and 1 to 10 ng/ml of IL-6, for 4 days. The adipocytes were then assessed for differentiation using Sudan red. Ten nanograms of IL-6 per milliliter had the most pronounced inhibitory effect on differentiation, causing a 24% decrease in lipid accumulation. Lower concentrations of IL-6 had a modest inhibitory effect. Only 20 ng/ml of IL-1β was significantly inhibitory, reducing lipid accumulation by 17% (P, <0.05). Two concentrations of TNF-α were inhibitory (P, <0.05), but they reduced differentiation by only 10% (>2 ng/ml). These data support the hypothesis that TNF-α, IL-6, and IL-1β can also affect glucose transport by interfering with 3T3-L1 adipocyte differentiation.

FIG. 5.
Effects of TNF-α, IL-6, and IL-1β on 3T3-L1 adipocyte differentiation. 3T3-L1 cells were differentiated for 4 days with thioglycolate-elicited peritoneal macrophages in direct coculture or in transwells. Cells were fixed and stained with ...

DISCUSSION

This is a unique study, because it addresses how macrophage-adipocyte interactions progressively affect both macrophage and adipocyte function, a situation that very likely occurs as obesity develops in more than 1 billion adults worldwide (15). For example, the depression of fully differentiated adipocyte GLUT4 transcript levels in 3T3-L1 adipocytes by macrophages (Table (Table1)1) and macrophage cytokines (Table (Table3)3) and the observations that macrophage IL-1β and IL-6 transcript levels (Table (Table2)2) and cell membrane marker levels (Fig. (Fig.2)2) were altered by coculture with preadipocytes or adipocytes reaffirm the complex interaction that occurs between the two cell types (36). This complex interaction is also evidenced by data showing that direct contact between macrophages and adipocytes also affects cell responses independently of cytokines (e.g., IL-6 secretion [Fig. [Fig.11]).

Lumeng et al. reported moderately but significantly enhanced TNF secretion in macrophage-adipocyte cocultures over the level secreted by macrophages alone (24). Adipocytes also secrete TNF-α, IL-6, and IL-1α (16). Therefore, we accounted for the cytokines that were made by both the adipocytes and the macrophages. Indeed, when those concentrations are accounted for, except for IL-6 in direct cocultures of macrophages and adipocytes, the amounts of secreted TNF-α, IL-6, and IL-1 were significantly less than what macrophages and adipocytes made independently (Fig. (Fig.1).1). These data suggest that the cytokines either were metabolized, were posttranscriptionally downregulated because of paracrine, autocrine, and cell-cell interactions, or were degraded. It has been reported that cytokine concentrations are lower in cocultures because secretion of adiponectin by adipocytes suppresses TNF-α and IL-6 production (2). The concentration of adiponectin detected in our macrophage-adipocyte cocultures was much lower than the reported in vitro inhibitory concentration (1.2 mg/ml versus 30 mg/ml). Therefore, it is unlikely that adiponectin had inhibited IL-6 and TNF-α expression. We also found increased numbers of macrophage IL-6 transcripts when preadipocytes or adipocytes and differentiated C2D macrophages were cocultured (Table (Table2).2). Although transcription does not always translate into protein production (12), it would appear that increased use, metabolism, or posttranscriptional regulation most likely changed the cytokine concentrations detected in the cells in the coculture.

Our data support previous findings that TNF-α, IL-6, and IL-1β contribute to insulin resistance by inhibiting the expression of GLUT4 in 3T3-L1 adipocytes (Table (Table33 and Fig. Fig.3).3). Although it is accepted that TNF-α affects GLUT4 protein synthesis (24) and GLUT4 gene transcription (34) through various signal transduction pathways (14, 23, 25), the role of IL-6 in the induction of insulin resistance is controversial. Some have demonstrated that IL-6 promoted insulin resistance by decreasing the expression of IRS-1 and GLUT4 (21, 30), while others have reported that IL-6 enhanced glucose transport in 3T3-L1 adipocytes (35). Carey et al. showed that treatment with IL-6 for 120 min increased fatty acid oxidation, basal and insulin-stimulated glucose uptake, and translocation of GLUT4 to the plasma membrane in L6 myotubes (5). Our data suggest that IL-6 may be just as important as TNF-α, or more important, since it completely inhibited Akt phosphorylation 30 min after insulin stimulation (Fig. (Fig.4).4). It is possible that shorter treatments or different IL-6 concentrations may have different impacts. However, IL-6 also contributed to insulin resistance by inhibiting the expression of GLUT4 in 3T3-L1 adipocytes (Table (Table33 and Fig. Fig.33).

IL-1β also lowered the number of GLUT4 transcripts and the amount of GLUT4 protein in 3T3-L1 adipocytes. Interestingly, whereas TNF-α and IL-6 treatments were effective at cytokine concentrations in ranges close to those found in our macrophage-adipocyte cocultures (e.g., for IL-6, 8 ng/ml was detected, and 10 ng/ml was needed for activation; for TNF-α, 250 pg/ml was detected, and 2 ng/ml was needed for activation), we had to use extremely high concentrations of recombinant IL-1β (20 ng/ml was needed for activation compared to 10 pg/ml detected in cocultures) to see an effect. Jager et al. (19) also found that 20 ng/ml of IL-1β inhibited insulin-stimulated GLUT4 but not GLUT1 function in adipocytes. Therefore, it is clear that high concentrations of IL-1β can be inhibitory. Others have reported that treating adipocytes chronically with IL-1β (e.g., 6 to 10 days) inhibited signal transduction important to glucose transport (IRS-1, Akt, and Erk 1/2) in both human and mouse adipocytes (22). However, we did not see an effect of IL-1β on Akt phosphorylation within 30 min of insulin stimulation. IL-1β may function more effectively when it works in conjunction with IL-6 and TNF-α. However, combinations of IL-1β (1 and 20 ng/ml), TNF-α (0.5 and 2 ng/ml), and IL-6 (2 and 10 ng/ml) did not have additive effects on the inhibition of 3T3-L1 adipocyte differentiation compared to the impact of TNF-α or IL-6 alone (data not shown). Therefore, the role of IL-1β may be peripheral to that of the other two major proinflammatory cytokines.

Macrophages not only downregulated the number of GLUT4 transcripts; they also inhibited the differentiation of adipocytes by secreting cytokines (Fig. (Fig.5).5). Ιt is now recognized that the stromal-vascular compartment of adipose tissue contains various precursor and stem cells, which populate different cell lineages in vivo and in vitro (1). Among the stromal cells, there are preadipocytes that differentiate into adipocytes (1). Weisberg et al. (41) and Xu et al. (46) reported that inflammatory macrophages accumulated around small adipocytes and could promote apoptosis. Constant et al. reported that macrophage-conditioned medium inhibited the differentiation of 3T3-L1 and human abdominal preadipocytes (8). We confirmed that IL-1β and TNF-α inhibited adipogenesis directly (31, 37). This inhibition probably was caused by suppression of PPAR-γ and NF-κB (45). However, we did not test that hypothesis directly. It is interesting that fully differentiated adipocytes promoted the upregulation of Mac-2 on PEC-C2D macrophages (Fig. (Fig.2).2). However, we found that PEC-C2D macrophages downregulated both CD11b and Mac-2 when cocultured with preadipocytes in vitro (Fig. (Fig.2B).2B). Therefore, not only is adipogenesis inhibited by the presence of macrophages (20), but macrophage activation/differentiation was also inhibited or activated depending on whether macrophages were interacting with preadipocytes or with adipocytes.

In summary, our data support the hypothesis that communication between macrophages and adipocytes promotes the onset of insulin resistance. Adipocytes signal increased production of macrophage proinflammatory cytokines. On the other hand, macrophages induce insulin resistance in adipocytes by secreting a proinflammatory cocktail that can affect insulin action by downregulating GLUT4 and by inhibiting adipocyte differentiation, which further lowers GLUT4 levels. Whereas others have suggested that TNF-α plays a leading role in this process (24, 31), our data suggest that IL-6 may be a more potent contributor under some circumstances. IL-6 was the only cytokine whose levels were increased in peritoneal (PC) macrophage-adipocyte cocultures (Fig. (Fig.1).1). IL-6 was the only cytokine to completely inhibit Akt phosphorylation (Fig. (Fig.4).4). It also had the most significant impact on adipocyte differentiation (Fig. (Fig.5).5). This suggestion does not imply that IL-1β and TNF-α do not affect adipocytes. Indeed, all these proinflammatory cytokines impaired adipocyte function in ways that would have contributed to the development of insulin resistance. We suggest that IL-1β and TNF-α acted in synergy with IL-6. Therefore, the onset of insulin resistance presents an interesting challenge because of the multifactorial impact of numerous cytokines and diverse differentiation stages of cells in the adipose tissue in the adipocyte-macrophage interaction.

Acknowledgments

We thank Tammy Koopman for assistance with flow cytometry. We thank Betsey Potts and Alison Luce-Fedrow for laboratory assistance with these studies.

This project has been supported in part by American Heart Association grant 0950036G; NIH grants AI55052, AI052206, RR16475, RR17686, and RR17708; NASA grant NNX08BA91G; and funding from Diabetes UK, the Wellcome Trust, the European Commission (grant HEALTH-F4-2008-223450), the Kansas Agriculture Experiment station, and the Terry C. Johnson Center for Basic Cancer Research.

Footnotes

[down-pointing small open triangle]Published ahead of print on 17 February 2010.

Kansas Agriculture Experiment Station publication 08-175-J.

REFERENCES

1. Ailhaud, G. 2006. Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome. C. R. Biol. 329:570-577. [PubMed]
2. Ajuwon, K. M., and M. E. Spurlock. 2005. Adiponectin inhibits LPS-induced NF-κB activation and IL-6 production and increases PPARγ2 expression in adipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288:R1220-R1225. [PubMed]
3. Beharka, A. A., J. W. Armstrong, and S. K. Chapes. 1998. Macrophage cell lines derived from major histocompatibility complex II-negative mice. In Vitro Cell. Dev. Biol. Anim. 34:499-507. [PubMed]
4. Blüher, M., M. Fasshauer, A. Tonjes, J. Kratzsch, M. R. Schon, and R. Paschke. 2005. Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism. Exp. Clin. Endocrinol. Diabetes 113:534-537. [PubMed]
5. Carey, A. L., G. R. Steinberg, S. L. Macaulay, W. G. Thomas, A. G. Holmes, G. Ramm, O. Prelovsek, C. Hohnen-Behrens, M. J. Watt, D. E. James, B. E. Kemp, B. K. Pedersen, and M. A. Febbraio. 2006. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 55:2688-2697. [PubMed]
6. Chacón, M. R., J. M. Fernández-Real, C. Richart, A. Megia, J. M. Gómez, M. Miranda, E. Caubet, R. Pastor, C. Masdevall, N. Vilarrasa, W. Ricard, and J. Vendrell. 2007. Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study. Obesity (Silver Spring) 15:664-672. [PubMed]
7. Chapes, S. K., and A. A. Beharka. 1995. Lipopolysaccharide is required for the lethal effects of enterotoxin B after d-galactosamine sensitization. J. Endotoxin Res. 2:263-271.
8. Constant, V. A., A. Gagnon, A. Landry, and A. Sorisky. 2006. Macrophage-conditioned medium inhibits the differentiation of 3T3-L1 and human abdominal preadipocytes. Diabetologia 49:1402-1411. [PubMed]
9. De Taeye, B., T. Novitskaya, O. P. McGuinness, L. Gleaves, M. Medda, J. W. Covington, and D. E. Vaughan. 2007. Macrophage TNF-α contributes to insulin resistance and hepatic steatosis in diet-induced obesity. Am. J. Physiol. Endocrinol. Metab. 293:E713-E725. [PubMed]
10. Dinarello, C. A. 1997. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 112:321S-329S. [PubMed]
11. Dugani, C. B., and A. Klip. 2005. Glucose transporter 4: cycling, compartments and controversies. EMBO Rep. 6:1137-1142. [PubMed]
12. Eierman, D. F., C. E. Johnson, and J. S. Haskill. 1989. Human monocyte inflammatory mediator gene expression is selectively regulated by adherence substrates. J. Immunol. 142:1970-1976. [PubMed]
13. Farmer, S. R. 2006. Transcriptional control of adipocyte formation. Cell Metab. 4:263-273. [PMC free article] [PubMed]
14. Fernández-Veledo, S., R. Hernandez, T. Teruel, J. A. Mas, M. Ros, and M. Lorenzo. 2006. Ceramide mediates TNF-α-induced insulin resistance on GLUT4 gene expression in brown adipocytes. Arch. Physiol. Biochem. 112:13-22. [PubMed]
15. Guilbert, J. J. 2003. The world health report 2002—reducing risks, promoting healthy life. Educ. Health (Abingdon, Engl.) 16:230. [PubMed]
16. Guzik, T. J., D. Mangalat, and R. Korbut. 2006. Adipocytokines—novel link between inflammation and vascular function? J. Physiol. Pharmacol. 57:505-528. [PubMed]
17. Hauner, H. 2004. The new concept of adipose tissue function. Physiol. Behav. 83:653-658. [PubMed]
18. Hotamisligil, G. S. 2006. Inflammation and metabolic disorders. Nature 444:860-867. [PubMed]
19. Jager, J., T. Gremeaux, M. Cormont, Y. Le Marchand-Brustel, and J. F. Tanti. 2007. Interleukin-1β-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148:241-251. [PMC free article] [PubMed]
20. Lacasa, D., S. Taleb, M. Keophiphath, A. Miranville, and K. Clement. 2007. Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes. Endocrinology 148:868-877. [PubMed]
21. Lagathu, C., J. P. Bastard, M. Auclair, M. Maachi, J. Capeau, and M. Caron. 2003. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem. Biophys. Res. Commun. 311:372-379. [PubMed]
22. Lagathu, C., L. Yvan-Charvet, J. P. Bastard, M. Maachi, A. Quignard-Boulange, J. Capeau, and M. Caron. 2006. Long-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes. Diabetologia 49:2162-2173. [PubMed]
23. Long, S. D., and P. H. Pekala. 1996. Lipid mediators of insulin resistance: ceramide signalling down-regulates GLUT4 gene transcription in 3T3-L1 adipocytes. Biochem. J. 319(Pt 1):179-184. [PubMed]
24. Lumeng, C. N., S. M. Deyoung, and A. R. Saltiel. 2007. Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am. J. Physiol. Endocrinol. Metab. 292:E166-E174. [PubMed]
25. Medina, E. A., R. R. Afsari, T. Ravid, S. S. Castillo, K. L. Erickson, and T. Goldkorn. 2005. Tumor necrosis factor-α decreases Akt protein levels in 3T3-L1 adipocytes via the caspase-dependent ubiquitination of Akt. Endocrinology 146:2726-2735. [PubMed]
26. Neels, J. G., and J. M. Olefsky. 2006. Inflamed fat: what starts the fire? J. Clin. Invest. 116:33-35. [PMC free article] [PubMed]
27. Pfaffl, M. W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45. [PMC free article] [PubMed]
28. Potts, B. E., and S. K. Chapes. 2008. Functions of C2D macrophage cells after adoptive transfer. J. Leukoc. Biol. 83:602-609. [PubMed]
29. Potts, B. E., M. L. Hart, L. L. Snyder, D. Boyle, D. A. Mosier, and S. K. Chapes. 2008. Differentiation of C2D macrophage cells after adoptive transfer. Clin. Vaccine Immunol. 15:243-252. [PMC free article] [PubMed]
30. Rotter, V., I. Nagaev, and U. Smith. 2003. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects. J. Biol. Chem. 278:45777-45784. [PubMed]
31. Ruan, H., N. Hacohen, T. R. Golub, L. Van Parijs, and H. F. Lodish. 2002. Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-κB activation by TNF-α is obligatory. Diabetes 51:1319-1336. [PubMed]
32. Schenk, S., M. Saberi, and J. M. Olefsky. 2008. Insulin sensitivity: modulation by nutrients and inflammation. J. Clin. Invest. 118:2992-3002. [PMC free article] [PubMed]
33. Spranger, J., A. Kroke, M. Mohlig, K. Hoffmann, M. M. Bergmann, M. Ristow, H. Boeing, and A. F. Pfeiffer. 2003. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52:812-817. [PubMed]
34. Stephens, J. M., and P. H. Pekala. 1991. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-α. J. Biol. Chem. 266:21839-21845. [PubMed]
35. Stouthard, J. M., R. P. Oude Elferink, and H. P. Sauerwein. 1996. Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 220:241-245. [PubMed]
36. Suganami, T., J. Nishida, and Y. Ogawa. 2005. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor α. Arterioscler. Thromb. Vasc. Biol. 25:2062-2068. [PubMed]
37. Suzawa, M., I. Takada, J. Yanagisawa, F. Ohtake, S. Ogawa, T. Yamauchi, T. Kadowaki, Y. Takeuchi, H. Shibuya, Y. Gotoh, K. Matsumoto, and S. Kato. 2003. Cytokines suppress adipogenesis and PPAR-γ function through the TAK1/TAB1/NIK cascade. Nat. Cell Biol. 5:224-230. [PubMed]
38. Trayhurn, P., and I. S. Wood. 2005. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem. Soc. Trans. 33:1078-1081. [PubMed]
39. Uysal, K. T., S. M. Wiesbrock, M. W. Marino, and G. S. Hotamisligil. 1997. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389:610-614. [PubMed]
40. Ventre, J., T. Doebber, M. Wu, K. MacNaul, K. Stevens, M. Pasparakis, G. Kollias, and D. E. Moller. 1997. Targeted disruption of the tumor necrosis factor-α gene: metabolic consequences in obese and nonobese mice. Diabetes 46:1526-1531. [PubMed]
41. Weisberg, S. P., D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante, Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112:1796-1808. [PMC free article] [PubMed]
42. Wellen, K. E., and G. S. Hotamisligil. 2005. Inflammation, stress, and diabetes. J. Clin. Invest. 115:1111-1119. [PMC free article] [PubMed]
43. Xie, L., D. Boyle, D. Sanford, P. E. Scherer, J. E. Pessin, and S. Mora. 2006. Intracellular trafficking and secretion of adiponectin is dependent on GGA-coated vesicles. J. Biol. Chem. 281:7253-7259. [PubMed]
44. Xie, L., C. P. O'Reilly, S. K. Chapes, and S. Mora. 2008. Adiponectin and leptin are secreted through distinct trafficking pathways in adipocytes. Biochim. Biophys. Acta 1782:99-108. [PMC free article] [PubMed]
45. Xing, H., J. P. Northrop, J. R. Grove, K. E. Kilpatrick, J. L. Su, and G. M. Ringold. 1997. TNF α-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARγ without effects on Pref-1 expression. Endocrinology 138:2776-2783. [PubMed]
46. Xu, H., G. T. Barnes, Q. Yang, G. Tan, D. Yang, C. J. Chou, J. Sole, A. Nichols, J. S. Ross, L. A. Tartaglia, and H. Chen. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112:1821-1830. [PMC free article] [PubMed]
47. Zoccali, C., F. Mallamaci, and G. Tripepi. 2003. Adipose tissue as a source of inflammatory cytokines in health and disease: focus on end-stage renal disease. Kidney Int. Suppl. 84:S65-S68. [PubMed]

Articles from Clinical and Vaccine Immunology : CVI are provided here courtesy of American Society for Microbiology (ASM)